ACADIA Pharmaceuticals is trading at $20.88, up +5.94%, in pre-market as healthcare stocks attract buying amid a rotation away from AI and technology shares.
- The shift away from AI and technology shares took place during the prior session.
- No fresh company announcement was found. An October 15 shareholder investigation announcement was not established as the cause of the gain.